MetaADEDB 2.0 @ LMMD
MDV 3100
(WXCXUHSOUPDCQV-UHFFFAOYSA-N)
Structure
SMILES
CNC(=O)c1ccc(cc1F)N1C(=S)N(C(=O)C1(C)C)c1ccc(c(c1)C(F)(F)F)C#N
Type(s)
Approved
ATC code(s)
L02BB04
Molecular Formula:
C21H16F4N4O2S
Molecular Weight:
464.436
Log P:
4.5134
Hydrogen Bond Acceptor:
7
Hydrogen Bond Donor:
1
TPSA:
108.53
CAS Number(s):
915087-33-1
Synonym(s)
1.
MDV 3100
2.
MDV-3100
3.
MDV3100
4.
enzalutamide
External Link(s)
MeSHC540278
PubChem Compound15951529
BindingDB50425732
ChEBI68534
CHEMBLCHEMBL1082407
DrugBankDB08899
DrugCentral4628
IUPHAR/BPS Guide to PHARMACOLOGY6812
KEGGdr:D10218
Therapeutic Target DatabaseD0QK5X
D0M1YR
ZINC34806477
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 4868
Canada Vigilance: 27
Canada Vigilance
SIDER
US FAERS
2Malignant neoplasm progressionFAERS: 2574
Canada Vigilance: 86
Canada Vigilance
US FAERS
3Drug ineffectiveFAERS: 2259
Canada Vigilance: 45
Canada Vigilance
US FAERS
4AstheniaFAERS: 1805
Canada Vigilance: 10
Canada Vigilance
SIDER
US FAERS
5NauseaFAERS: 1498
Canada Vigilance: 3
Canada Vigilance
US FAERS
6DizzinessFAERS: 1410
Canada Vigilance: 5
Canada Vigilance
SIDER
US FAERS
7Back PainFAERS: 1140
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
8ArthralgiaFAERS: 928
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
9Weight decreasedFAERS: 822
Canada Vigilance: 4
Canada Vigilance
US FAERS
10HeadacheFAERS: 783
Canada Vigilance: 3
Canada Vigilance
SIDER
US FAERS
11ConstipationFAERS: 766US FAERS
12Peripheral swellingFAERS: 725
Canada Vigilance: 3
Canada Vigilance
US FAERS
13MalaiseFAERS: 700
Canada Vigilance: 13
Canada Vigilance
US FAERS
14Drug dose omissionFAERS: 675US FAERS
15PainFAERS: 597
Canada Vigilance: 4
Canada Vigilance
US FAERS
16VomitingFAERS: 510
Canada Vigilance: 6
Canada Vigilance
US FAERS
17Abdominal discomfortFAERS: 470
Canada Vigilance: 1
Canada Vigilance
US FAERS
18MyalgiaFAERS: 458US FAERS
19SomnolenceFAERS: 443US FAERS
20Product size issueFAERS: 363
Canada Vigilance: 5
Canada Vigilance
US FAERS
21Memory impairmentFAERS: 355
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
22DysgeusiaFAERS: 350US FAERS
23Bone painFAERS: 348US FAERS
24Feeling abnormalFAERS: 314
Canada Vigilance: 2
Canada Vigilance
US FAERS
25Inappropriate schedule of drug administrationFAERS: 306US FAERS
26Urinary tract infectionFAERS: 270
Canada Vigilance: 2
Canada Vigilance
US FAERS
27Cerebrovascular accidentFAERS: 268
Canada Vigilance: 11
Canada Vigilance
US FAERS
28PneumoniaFAERS: 262
Canada Vigilance: 4
Canada Vigilance
SIDER
US FAERS
29AnxietyFAERS: 247SIDER
US FAERS
30AmnesiaFAERS: 244SIDER
US FAERS
31PruritusFAERS: 224
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
32Joint swellingFAERS: 215US FAERS
33Musculoskeletal PainFAERS: 212
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
34DehydrationFAERS: 201US FAERS
35NasopharyngitisFAERS: 179SIDER
US FAERS
36TremorFAERS: 173US FAERS
37General physical health deteriorationFAERS: 169
Canada Vigilance: 7
Canada Vigilance
US FAERS
38Adverse eventFAERS: 168
Canada Vigilance: 1
Canada Vigilance
US FAERS
39Chest PainFAERS: 166US FAERS
40Product storage errorFAERS: 159US FAERS
41VertigoFAERS: 150SIDER
US FAERS
42FlatulenceFAERS: 145US FAERS
43Blood urine presentFAERS: 144
Canada Vigilance: 1
Canada Vigilance
US FAERS
44Visual ImpairmentFAERS: 144US FAERS
45Myocardial InfarctionFAERS: 141
Canada Vigilance: 3
Canada Vigilance
US FAERS
46HypersomniaFAERS: 139
Canada Vigilance: 1
Canada Vigilance
US FAERS
47LethargyFAERS: 139US FAERS
48AlopeciaFAERS: 132
Canada Vigilance: 1
Canada Vigilance
US FAERS
49Incorrect product storageFAERS: 124US FAERS
50AgeusiaFAERS: 123
Canada Vigilance: 1
Canada Vigilance
US FAERS
51DementiaFAERS: 123
Canada Vigilance: 1
Canada Vigilance
US FAERS
52EpistaxisFAERS: 120
Canada Vigilance: 2
Canada Vigilance
SIDER
US FAERS
53DyspepsiaFAERS: 118
Canada Vigilance: 2
Canada Vigilance
US FAERS
54Musculoskeletal stiffnessFAERS: 115SIDER
US FAERS
55HypotensionFAERS: 104
Canada Vigilance: 2
Canada Vigilance
US FAERS
56Abdominal PainFAERS: 103US FAERS
57InfectionFAERS: 97
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
58Restless Legs SyndromeFAERS: 93US FAERS
59Product physical issueFAERS: 92US FAERS
60Dry skinFAERS: 91SIDER
US FAERS
61Disease ProgressionFAERS: 89
Canada Vigilance: 5
Canada Vigilance
US FAERS
62Wrong technique in product usage processFAERS: 88
Canada Vigilance: 5
Canada Vigilance
US FAERS
63Neck PainFAERS: 87US FAERS
64ChillsFAERS: 85
Canada Vigilance: 1
Canada Vigilance
US FAERS
65Oropharyngeal painFAERS: 83
Canada Vigilance: 1
Canada Vigilance
US FAERS
66Burning sensationFAERS: 82US FAERS
67Circumstance or information capable of leading to medication errorFAERS: 81US FAERS
68DisorientationFAERS: 80US FAERS
69Throat irritationFAERS: 80
Canada Vigilance: 1
Canada Vigilance
US FAERS
70treatment failureFAERS: 79
Canada Vigilance: 1
Canada Vigilance
US FAERS
71ArthritisFAERS: 78US FAERS
72InfluenzaFAERS: 78US FAERS
73SwellingFAERS: 78US FAERS
74DysuriaFAERS: 76
Canada Vigilance: 1
Canada Vigilance
US FAERS
75FlushingFAERS: 76US FAERS
76ErythemaFAERS: 73US FAERS
77HypersensitivityFAERS: 73
Canada Vigilance: 1
Canada Vigilance
US FAERS
78ThrombosisFAERS: 73US FAERS
79Night sweatsFAERS: 71US FAERS
80Blood glucose increasedFAERS: 69US FAERS
81Prescribed underdoseFAERS: 69US FAERS
82Intentional dose omissionFAERS: 67US FAERS
83SepsisFAERS: 67SIDER
US FAERS
84OverdoseFAERS: 66US FAERS
85CystitisFAERS: 62
Canada Vigilance: 1
Canada Vigilance
US FAERS
86Atrial FibrillationFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Urinary IncontinenceFAERS: 61
Canada Vigilance: 1
Canada Vigilance
US FAERS
88TinnitusFAERS: 60US FAERS
89DysphoniaFAERS: 59US FAERS
90Unevaluable eventFAERS: 59
Canada Vigilance: 2
Canada Vigilance
US FAERS
91Limb discomfortFAERS: 58
Canada Vigilance: 1
Canada Vigilance
US FAERS
92UrticariaFAERS: 58US FAERS
93Productive CoughFAERS: 57US FAERS
94Hospice CareFAERS: 56US FAERS
95Musculoskeletal chest painFAERS: 56US FAERS
96Urinary RetentionFAERS: 56
Canada Vigilance: 1
Canada Vigilance
US FAERS
97RetchingFAERS: 55US FAERS
98SinusitisFAERS: 55SIDER
US FAERS
99Chest discomfortFAERS: 54US FAERS
100AbasiaFAERS: 53US FAERS
101Product dose omissionFAERS: 53US FAERS
102NocturiaFAERS: 52US FAERS
103SyncopeFAERS: 51US FAERS
104ChokingFAERS: 49
Canada Vigilance: 2
Canada Vigilance
US FAERS
105NervousnessFAERS: 49US FAERS
106Incorrect dose administeredFAERS: 48
Canada Vigilance: 1
Canada Vigilance
US FAERS
107Gait inabilityFAERS: 47US FAERS
108Feeling ColdFAERS: 46US FAERS
109Full blood count decreasedFAERS: 45US FAERS
110White blood cell count decreasedFAERS: 43US FAERS
111BedriddenFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
112Joint stiffnessFAERS: 42US FAERS
113Foreign body in respiratory tractFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
114GoutFAERS: 41
Canada Vigilance: 1
Canada Vigilance
US FAERS
115Intentional product misuseFAERS: 40US FAERS
116NephrolithiasisFAERS: 39
Canada Vigilance: 2
Canada Vigilance
US FAERS
117RestlessnessFAERS: 39
Canada Vigilance: 2
Canada Vigilance
US FAERS
118ThrombocytopeniaFAERS: 39
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
119Loss of personal independence in daily activitiesFAERS: 37
Canada Vigilance: 1
Canada Vigilance
US FAERS
120BlindnessFAERS: 36US FAERS
121Blood glucose decreasedFAERS: 35US FAERS
122Depressed moodFAERS: 35US FAERS
123DiplopiaFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
124Drug prescribing errorFAERS: 35US FAERS
125Intestinal ObstructionFAERS: 35
Canada Vigilance: 1
Canada Vigilance
US FAERS
126PalpitationsFAERS: 34
Canada Vigilance: 1
Canada Vigilance
US FAERS
127Product supply issueFAERS: 34US FAERS
128Respiratory FailureFAERS: 34US FAERS
129Wrong technique in drug usage processFAERS: 34US FAERS
130Head discomfortFAERS: 33US FAERS
131Mental status changesFAERS: 33US FAERS
132ChromaturiaFAERS: 32US FAERS
133SneezingFAERS: 32US FAERS
134HypophagiaFAERS: 31US FAERS
135Limb injuryFAERS: 31US FAERS
136Terminal stateFAERS: 31
Canada Vigilance: 5
Canada Vigilance
US FAERS
137Accidental overdoseFAERS: 30US FAERS
138ArthropathyFAERS: 30US FAERS
139Cardiac ArrestFAERS: 30US FAERS
140DysarthriaFAERS: 30US FAERS
141EructationFAERS: 30US FAERS
142IncontinenceFAERS: 30US FAERS
143CataractFAERS: 29US FAERS
144DeafnessFAERS: 29US FAERS
145Feeling jitteryFAERS: 29US FAERS
146Mental impairmentFAERS: 28US FAERS
147Musculoskeletal discomfortFAERS: 28SIDER
US FAERS
148Pelvic PainFAERS: 28US FAERS
149CellulitisFAERS: 27US FAERS
150Intentional product use issueFAERS: 27US FAERS
151No adverse eventFAERS: 27US FAERS
152Pulmonary EmbolismFAERS: 27US FAERS
153SluggishnessFAERS: 27US FAERS
154Blood sodium decreasedFAERS: 26US FAERS
155Diabetes MellitusFAERS: 26US FAERS
156Initial insomniaFAERS: 26US FAERS
157NeuralgiaFAERS: 26
Canada Vigilance: 1
Canada Vigilance
US FAERS
158Acute kidney injuryFAERS: 25US FAERS
159BronchitisFAERS: 25SIDER
US FAERS
160Product quality issueFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
161ToothacheFAERS: 25
Canada Vigilance: 1
Canada Vigilance
US FAERS
162Activities of daily living impairedFAERS: 24US FAERS
163Cancer PainFAERS: 24US FAERS
164Poor quality drug administeredFAERS: 24US FAERS
165Product packaging quantity issueFAERS: 24US FAERS
166AphasiaFAERS: 23US FAERS
167Blood potassium decreasedFAERS: 23US FAERS
168DiscomfortFAERS: 23
Canada Vigilance: 1
Canada Vigilance
US FAERS
169ApathyFAERS: 22US FAERS
170Breast tendernessFAERS: 22US FAERS
171HypokinesiaFAERS: 22US FAERS
172Incorrect storage of drugFAERS: 22US FAERS
173Joint injuryFAERS: 22US FAERS
174Muscle strainFAERS: 22US FAERS
175Bowel movement irregularityFAERS: 21US FAERS
176Clostridium difficile infectionFAERS: 21US FAERS
177Device related infectionFAERS: 21US FAERS
178Eye painFAERS: 21US FAERS
179Product use in unapproved indicationFAERS: 21US FAERS
180Toxicity to various agentsFAERS: 21
Canada Vigilance: 1
Canada Vigilance
US FAERS
181Lip swellingFAERS: 20US FAERS
182AgitationFAERS: 19US FAERS
183Cerebral InfarctionFAERS: 19US FAERS
184Drug dispensing errorFAERS: 19US FAERS
185Ear discomfortFAERS: 19US FAERS
186LymphadenopathyFAERS: 19US FAERS
187Medication residue presentFAERS: 19US FAERS
188Nipple painFAERS: 19US FAERS
189Posterior reversible encephalopathy syndromeFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
190Quality of life decreasedFAERS: 19
Canada Vigilance: 1
Canada Vigilance
US FAERS
191Blood potassium increasedFAERS: 18US FAERS
192Depressed Level of ConsciousnessFAERS: 18US FAERS
193Erectile dysfunctionFAERS: 18US FAERS
194Mood swingsFAERS: 18US FAERS
195Product use complaintFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
196Rash erythematousFAERS: 18US FAERS
197DeliriumFAERS: 17US FAERS
198Drug effect incompleteFAERS: 17US FAERS
199EpilepsyFAERS: 17US FAERS
200GastritisFAERS: 17US FAERS
201Pericardial effusionFAERS: 17US FAERS
202Pulmonary congestionFAERS: 17US FAERS
203Secretion dischargeFAERS: 17US FAERS
204Therapy cessationFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
205Therapy non-responderFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
206Blood cholesterol increasedFAERS: 16US FAERS
207Blood count abnormalFAERS: 16US FAERS
208Blood creatinine increasedFAERS: 16US FAERS
209Cold sweatFAERS: 16US FAERS
210InflammationFAERS: 16US FAERS
211PancytopeniaFAERS: 16US FAERS
212Poor peripheral circulationFAERS: 16US FAERS
213Product taste abnormalFAERS: 16US FAERS
214Renal painFAERS: 16
Canada Vigilance: 1
Canada Vigilance
US FAERS
215nervous system disorderFAERS: 16SIDER
US FAERS
216Back disorderFAERS: 15US FAERS
217Blood pressure fluctuationFAERS: 15US FAERS
218Cerebral disorderFAERS: 15US FAERS
219Eye irritationFAERS: 15US FAERS
220Inappropriate schedule of product administrationFAERS: 15
Canada Vigilance: 4
Canada Vigilance
US FAERS
221Muscle tightnessFAERS: 15US FAERS
222Oncologic complicationFAERS: 15US FAERS
223Product use issueFAERS: 15US FAERS
224SciaticaFAERS: 15US FAERS
225Therapeutic response unexpectedFAERS: 15US FAERS
226jaundiceFAERS: 15US FAERS
227Blood testosterone decreasedFAERS: 14US FAERS
228Expired product administeredFAERS: 14US FAERS
229General physical condition abnormalFAERS: 14US FAERS
230GlaucomaFAERS: 14US FAERS
231HyperchlorhydriaFAERS: 14US FAERS
232PallorFAERS: 14US FAERS
233Poor quality sleepFAERS: 14US FAERS
234StomatitisFAERS: 14US FAERS
235StressFAERS: 14US FAERS
236Temperature intoleranceFAERS: 14US FAERS
237Tooth InfectionFAERS: 14US FAERS
238Emotional disorderFAERS: 13US FAERS
239Failure to ThriveFAERS: 13US FAERS
240FractureFAERS: 13SIDER
US FAERS
241TachycardiaFAERS: 13US FAERS
242Unresponsive to stimuliFAERS: 13US FAERS
243WheezingFAERS: 13US FAERS
244AphoniaFAERS: 12US FAERS
245BradycardiaFAERS: 12US FAERS
246CholelithiasisFAERS: 12US FAERS
247ColitisFAERS: 12US FAERS
248Muscle FatigueFAERS: 12US FAERS
249Oral painFAERS: 12US FAERS
250Septic ShockFAERS: 12US FAERS
251ThirstFAERS: 12US FAERS
252Upper-airway cough syndromeFAERS: 12US FAERS
253Ankle FractureFAERS: 11US FAERS
254Blood alkaline phosphatase increasedFAERS: 11US FAERS
255Blood testosterone increasedFAERS: 11US FAERS
256Dental cariesFAERS: 11US FAERS
257Disease complicationFAERS: 11US FAERS
258DiverticulitisFAERS: 11
Canada Vigilance: 1
Canada Vigilance
US FAERS
259LazinessFAERS: 11US FAERS
260MalnutritionFAERS: 11US FAERS
261MetastasisFAERS: 11US FAERS
262Pancreatic carcinomaFAERS: 11US FAERS
263Personality ChangeFAERS: 11US FAERS
264Slow speechFAERS: 11US FAERS
265AsthmaFAERS: 10US FAERS
266Deep Vein ThrombosisFAERS: 10
Canada Vigilance: 2
Canada Vigilance
US FAERS
267Flank PainFAERS: 10US FAERS
268HypogeusiaFAERS: 10US FAERS
269Pulmonary thrombosisFAERS: 10US FAERS
270Skin UlcerFAERS: 10US FAERS
271UlcerFAERS: 10US FAERS
272Accidental exposure to productFAERS: 9US FAERS
273AngerFAERS: 9US FAERS
274Anorectal discomfortFAERS: 9US FAERS
275Blood glucose abnormalFAERS: 9US FAERS
276Blood glucose fluctuationFAERS: 9US FAERS
277Blood iron decreasedFAERS: 9US FAERS
278Blood magnesium decreasedFAERS: 9US FAERS
279Blood triglycerides increasedFAERS: 9US FAERS
280Cardiac FlutterFAERS: 9US FAERS
281FormicationFAERS: 9US FAERS
282Gastric ulcerFAERS: 9US FAERS
283PresyncopeFAERS: 9US FAERS
284Product packaging issueFAERS: 9US FAERS
285Skin irritationFAERS: 9US FAERS
286Tooth LossFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
287furuncleFAERS: 9US FAERS
288AbscessFAERS: 8US FAERS
289AcneFAERS: 8US FAERS
290Acute myocardial infarctionFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
291Alanine Aminotransferase IncreasedFAERS: 8US FAERS
292AnosmiaFAERS: 8US FAERS
293Apparent deathFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
294AsthenopiaFAERS: 8US FAERS
295Bone lesionFAERS: 8US FAERS
296Coronary Artery DiseaseFAERS: 8US FAERS
297Facial paralysisFAERS: 8
Canada Vigilance: 1
Canada Vigilance
US FAERS
298GingivitisFAERS: 8US FAERS
299HydronephrosisFAERS: 8US FAERS
300Metastatic NeoplasmFAERS: 8US FAERS
301Motion SicknessFAERS: 8US FAERS
302NeutropeniaFAERS: 8
Canada Vigilance: 1
Canada Vigilance
SIDER
US FAERS
303Osteonecrosis of JawFAERS: 8US FAERS
304RegurgitationFAERS: 8US FAERS
305Tooth ExtractionFAERS: 8US FAERS
306Ureteral stent insertionFAERS: 8US FAERS
307Urine flow decreasedFAERS: 8US FAERS
308Walking aid userFAERS: 8US FAERS
309Altered state of consciousnessFAERS: 7US FAERS
310AphagiaFAERS: 7US FAERS
311BradyphreniaFAERS: 7US FAERS
312Clostridium difficile colitisFAERS: 7US FAERS
313Disseminated Intravascular CoagulationFAERS: 7US FAERS
314DroolingFAERS: 7US FAERS
315Drug resistanceFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
316Gastrointestinal motility disorderFAERS: 7US FAERS
317Hip surgeryFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
318Hypertensive crisisFAERS: 7US FAERS
319ImmobileFAERS: 7US FAERS
320IncoherentFAERS: 7US FAERS
321Incorrect route of drug administrationFAERS: 7US FAERS
322LeukopeniaFAERS: 7SIDER
US FAERS
323LymphomaFAERS: 7US FAERS
324MYELODYSPLASTIC SYNDROMEFAERS: 7US FAERS
325Medication ErrorFAERS: 7US FAERS
326OsteomyelitisFAERS: 7US FAERS
327PancreatitisFAERS: 7US FAERS
328Product label issueFAERS: 7US FAERS
329Respiratory distressFAERS: 7US FAERS
330Stevens-Johnson SyndromeFAERS: 7US FAERS
331Throat cancerFAERS: 7US FAERS
332Urinary tract obstructionFAERS: 7US FAERS
333Vitreous floatersFAERS: 7US FAERS
334Aortic AneurysmFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
335Arthropod biteFAERS: 6US FAERS
336AscitesFAERS: 6US FAERS
337Aspartate Aminotransferase IncreasedFAERS: 6US FAERS
338AtaxiaFAERS: 6US FAERS
339Atrial FlutterFAERS: 6US FAERS
340Basal cell carcinomaFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
341Complication associated with deviceFAERS: 6US FAERS
342CystFAERS: 6US FAERS
343Device occlusionFAERS: 6US FAERS
344DysgraphiaFAERS: 6US FAERS
345EczemaFAERS: 6US FAERS
346Extra dose administeredFAERS: 6US FAERS
347Facial PainFAERS: 6US FAERS
348HypothyroidismFAERS: 6US FAERS
349LaryngitisFAERS: 6SIDER
US FAERS
350Lower respiratory tract infectionFAERS: 6SIDER
US FAERS
351Nerve injuryFAERS: 6US FAERS
352Pain of skinFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
353Paranasal sinus hypersecretionFAERS: 6US FAERS
354PhotophobiaFAERS: 6US FAERS
355Prostatic specific antigen decreasedFAERS: 6US FAERS
356Retinal DetachmentFAERS: 6US FAERS
357RhinitisFAERS: 6SIDER
US FAERS
358Skin lesionFAERS: 6US FAERS
359StenosisFAERS: 6US FAERS
360Transaminases increasedFAERS: 6US FAERS
361Wound InfectionFAERS: 6US FAERS
362Angina PectorisFAERS: 5US FAERS
363AngioedemaFAERS: 5US FAERS
364Blood thyroid stimulating hormone increasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
365Blood urea increasedFAERS: 5US FAERS
366Bone density decreasedFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
367Bone scan abnormalFAERS: 5US FAERS
368CachexiaFAERS: 5US FAERS
369Cataract operationFAERS: 5US FAERS
370Completed SuicideFAERS: 5US FAERS
371Compression fractureFAERS: 5US FAERS
372CryingFAERS: 5US FAERS
373DermatitisFAERS: 5US FAERS
374Drug ineffective for unapproved indicationFAERS: 5US FAERS
375Ear congestionFAERS: 5US FAERS
376Ejection Fraction DecreasedFAERS: 5US FAERS
377Eye InfectionFAERS: 5US FAERS
378Fluid overloadFAERS: 5US FAERS
379Foreign body aspirationFAERS: 5US FAERS
380Gamma-Glutamyltransferase IncreasedFAERS: 5US FAERS
381GastroenteritisFAERS: 5US FAERS
382Gastrointestinal toxicityFAERS: 5US FAERS
383HepatotoxicityFAERS: 5US FAERS
384HerniaFAERS: 5US FAERS
385HungerFAERS: 5US FAERS
386HypotrichosisFAERS: 5US FAERS
387Infrequent bowel movementsFAERS: 5US FAERS
388Intervertebral Disc DegenerationFAERS: 5US FAERS
389MonoplegiaFAERS: 5US FAERS
390Nasal discomfortFAERS: 5US FAERS
391OnychoclasisFAERS: 5US FAERS
392Paranasal sinus discomfortFAERS: 5US FAERS
393Performance status decreasedFAERS: 5US FAERS
394PneumonitisFAERS: 5US FAERS
395PsoriasisFAERS: 5US FAERS
396Pulmonary FibrosisFAERS: 5US FAERS
397Pulmonary HypertensionFAERS: 5US FAERS
398Rehabilitation therapyFAERS: 5US FAERS
399Respiratory arrestFAERS: 5US FAERS
400RhabdomyolysisFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
401Rotator cuff syndromeFAERS: 5US FAERS
402Seizure like phenomenaFAERS: 5US FAERS
403Skin WrinklingFAERS: 5US FAERS
404SplenectomyFAERS: 5US FAERS
405Sudden deathFAERS: 5US FAERS
406Tinea PedisFAERS: 5US FAERS
407Urethral ObstructionFAERS: 5US FAERS
408Urethral intrinsic sphincter deficiencyFAERS: 5US FAERS
409skin abrasionFAERS: 5US FAERS
410Accidental underdoseFAERS: 4US FAERS
411Acute Coronary SyndromeFAERS: 4US FAERS
412Acute respiratory failureFAERS: 4US FAERS
413AneurysmFAERS: 4US FAERS
414AnuriaFAERS: 4US FAERS
415Atrioventricular BlockFAERS: 4US FAERS
416Atypical pneumoniaFAERS: 4US FAERS
417Bladder painFAERS: 4US FAERS
418Bladder spasmFAERS: 4US FAERS
419BlepharospasmFAERS: 4US FAERS
420CardiomegalyFAERS: 4US FAERS
421Catheter placementFAERS: 4US FAERS
422Catheter site infectionFAERS: 4US FAERS
423Central nervous system lesionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
424ColectomyFAERS: 4US FAERS
425Depression suicidalFAERS: 4US FAERS
426Drug administration errorFAERS: 4US FAERS
427Epigastric discomfortFAERS: 4US FAERS
428EscharFAERS: 4US FAERS
429Gastrointestinal infectionFAERS: 4US FAERS
430Genital swellingFAERS: 4US FAERS
431HyperacusisFAERS: 4US FAERS
432LacerationFAERS: 4US FAERS
433Liver AbscessFAERS: 4US FAERS
434Middle insomniaFAERS: 4US FAERS
435Oral candidiasisFAERS: 4US FAERS
436OsteoporosisFAERS: 4US FAERS
437PneumothoraxFAERS: 4US FAERS
438Product physical consistency issueFAERS: 4US FAERS
439Prostatic painFAERS: 4US FAERS
440Psychiatric symptomFAERS: 4US FAERS
441Radiation injuryFAERS: 4US FAERS
442Rectal dischargeFAERS: 4US FAERS
443Rheumatoid ArthritisFAERS: 4US FAERS
444Saliva alteredFAERS: 4US FAERS
445Scan abnormalFAERS: 4US FAERS
446Sinus operationFAERS: 4US FAERS
447Skin lacerationFAERS: 4US FAERS
448Slow response to stimuliFAERS: 4US FAERS
449SomnambulismFAERS: 4US FAERS
450Synovial CystFAERS: 4US FAERS
451Throat clearingFAERS: 4US FAERS
452Thyroid hormones decreasedFAERS: 4US FAERS
453VIIth nerve paralysisFAERS: 4US FAERS
454Abdominal massFAERS: 3US FAERS
455Abdominal rigidityFAERS: 3US FAERS
456Abdominal tendernessFAERS: 3US FAERS
457ArteriosclerosisFAERS: 3US FAERS
458Blood creatine phosphokinase increasedFAERS: 3US FAERS
459Blood creatinine abnormalFAERS: 3US FAERS
460BronchospasmFAERS: 3US FAERS
461BursitisFAERS: 3US FAERS
462CholecystitisFAERS: 3US FAERS
463ClaustrophobiaFAERS: 3US FAERS
464Corneal PerforationFAERS: 3US FAERS
465CystoscopyFAERS: 3US FAERS
466Dengue FeverFAERS: 3US FAERS
467Device fastener issueFAERS: 3US FAERS
468DiplegiaFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
469Early satietyFAERS: 3US FAERS
470EmbolismFAERS: 3US FAERS
471ExophthalmosFAERS: 3US FAERS
472Eye allergyFAERS: 3US FAERS
473Eyelid margin crustingFAERS: 3US FAERS
474Fear of fallingFAERS: 3US FAERS
475Feeding tube userFAERS: 3US FAERS
476Feeling of body temperature changeFAERS: 3US FAERS
477Food aversionFAERS: 3US FAERS
478Full blood count abnormalFAERS: 3US FAERS
479Full blood count increasedFAERS: 3US FAERS
480GangreneFAERS: 3US FAERS
481Gastric FistulaFAERS: 3US FAERS
482GastrostomyFAERS: 3US FAERS
483Glaucoma surgeryFAERS: 3US FAERS
484Hepatitis CFAERS: 3US FAERS
485HyperkeratosisFAERS: 3US FAERS
486HyperphagiaFAERS: 3US FAERS
487Impaired driving abilityFAERS: 3US FAERS
488Impaired quality of lifeFAERS: 3US FAERS
489InfarctionFAERS: 3US FAERS
490Intraocular pressure test abnormalFAERS: 3US FAERS
491Irritable Bowel SyndromeFAERS: 3US FAERS
492Lower respiratory tract congestionFAERS: 3US FAERS
493Lyme DiseaseFAERS: 3US FAERS
494Medical device implantationFAERS: 3US FAERS
495MeningitisFAERS: 3US FAERS
496Meniscus injuryFAERS: 3US FAERS
497Mouth swellingFAERS: 3US FAERS
498Muscle contusionFAERS: 3US FAERS
499Neutrophil count decreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
500NoduleFAERS: 3US FAERS
501Oropharyngeal discomfortFAERS: 3
Canada Vigilance: 2
Canada Vigilance
US FAERS
502Pancreatic NeoplasmFAERS: 3US FAERS
503PapuleFAERS: 3US FAERS
504Pathological fractureFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
505Penile size reducedFAERS: 3US FAERS
506PleurisyFAERS: 3US FAERS
507PolyneuropathyFAERS: 3US FAERS
508Product expiration date issueFAERS: 3US FAERS
509Prostate ablationFAERS: 3US FAERS
510Skin tightnessFAERS: 3US FAERS
511Sleep TalkingFAERS: 3US FAERS
512Spinal column stenosisFAERS: 3US FAERS
513SpondylitisFAERS: 3US FAERS
514Suicide attemptFAERS: 3US FAERS
515SunburnFAERS: 3US FAERS
516TonsillitisFAERS: 3US FAERS
517Urinary tract stoma complicationFAERS: 3US FAERS
518Urine output increasedFAERS: 3US FAERS
519Urine viscosity increasedFAERS: 3US FAERS
520Vascular occlusionFAERS: 3US FAERS
521VasculitisFAERS: 3US FAERS
522Vertebral lesionFAERS: 3US FAERS
523Vertebrobasilar InsufficiencyFAERS: 3US FAERS
524Wheelchair userFAERS: 3US FAERS
525Abdominal InfectionFAERS: 2US FAERS
526AcidosisFAERS: 2US FAERS
527AgranulocytosisFAERS: 2US FAERS
528AkathisiaFAERS: 2US FAERS
529Ammonia increasedFAERS: 2US FAERS
530AngioplastyFAERS: 2US FAERS
531Animal biteFAERS: 2US FAERS
532AppendicitisFAERS: 2US FAERS
533Arthropod stingFAERS: 2US FAERS
534AsphyxiaFAERS: 2US FAERS
535Atrial pressure increasedFAERS: 2US FAERS
536Autonomic nervous system imbalanceFAERS: 2US FAERS
537AversionFAERS: 2US FAERS
538Bacterial test positiveFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
539Biliary tract infectionFAERS: 2US FAERS
540Bladder NeoplasmFAERS: 2US FAERS
541Bladder cystFAERS: 2US FAERS
542Blood cholesterol abnormalFAERS: 2US FAERS
543Blood viscosity decreasedFAERS: 2US FAERS
544Brain scan abnormalFAERS: 2US FAERS
545Cardiac discomfortFAERS: 2US FAERS
546Cardiac dysfunctionFAERS: 2US FAERS
547Carotid artery occlusionFAERS: 2US FAERS
548Carpal Tunnel SyndromeFAERS: 2US FAERS
549Charles Bonnet SyndromeFAERS: 2US FAERS
550Choking sensationFAERS: 2US FAERS
551Cholecystitis infectiveFAERS: 2US FAERS
552CholelithotomyFAERS: 2US FAERS
553ClumsinessFAERS: 2US FAERS
554Cognitive linguistic deficitFAERS: 2US FAERS
555Consciousness fluctuatingFAERS: 2US FAERS
556Cortisol decreasedFAERS: 2US FAERS
557CytopeniaFAERS: 2US FAERS
558Decreased immune responsivenessFAERS: 2US FAERS
559Dental Restoration FailureFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
560Device malfunctionFAERS: 2US FAERS
561Diabetes mellitus inadequate controlFAERS: 2US FAERS
562Diffuse Large B-Cell LymphomaFAERS: 2US FAERS
563DisabilityFAERS: 2US FAERS
564DiverticulumFAERS: 2US FAERS
565Eating disorder symptomFAERS: 2US FAERS
566Electrolyte imbalanceFAERS: 2US FAERS
567Emergency CareFAERS: 2US FAERS
568Emotional distressFAERS: 2US FAERS
569Emotional povertyFAERS: 2US FAERS
570Endodontic procedureFAERS: 2US FAERS
571Enterococcal infectionFAERS: 2US FAERS
572EnuresisFAERS: 2US FAERS
573Enzyme level increasedFAERS: 2US FAERS
574Escherichia infectionFAERS: 2US FAERS
575Escherichia sepsisFAERS: 2US FAERS
576Escherichia urinary tract infectionFAERS: 2US FAERS
577Essential TremorFAERS: 2US FAERS
578Excessive cerumen productionFAERS: 2US FAERS
579Eyelid infectionFAERS: 2US FAERS
580Foaming at mouthFAERS: 2US FAERS
581Food PoisoningFAERS: 2US FAERS
582Food cravingFAERS: 2US FAERS
583Frustration tolerance decreasedFAERS: 2US FAERS
584Gastric DilatationFAERS: 2US FAERS
585Gastrointestinal bacterial infectionFAERS: 2US FAERS
586Gastrointestinal obstructionFAERS: 2US FAERS
587Gastrointestinal sounds abnormalFAERS: 2US FAERS
588General symptomFAERS: 2US FAERS
589Genital rashFAERS: 2US FAERS
590GlossitisFAERS: 2US FAERS
591HemiparesisFAERS: 2US FAERS
592HepatitisFAERS: 2US FAERS
593HepatomegalyFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
594Hernia painFAERS: 2US FAERS
595HomicideFAERS: 2US FAERS
596HordeolumFAERS: 2US FAERS
597HyperthyroidismFAERS: 2US FAERS
598IleusFAERS: 2US FAERS
599Immune thrombocytopenic purpuraFAERS: 2US FAERS
600Impaired work abilityFAERS: 2US FAERS
601Implantable defibrillator insertionFAERS: 2US FAERS
602Inappropriate affectFAERS: 2US FAERS
603Increased upper airway secretionFAERS: 2US FAERS
604Infected biteFAERS: 2US FAERS
605Inhibitory drug interactionFAERS: 2US FAERS
606Injection site infectionFAERS: 2US FAERS
607Intentional drug misuseFAERS: 2US FAERS
608Intermittent ClaudicationFAERS: 2US FAERS
609Intestinal PerforationFAERS: 2US FAERS
610Intestinal fibrosisFAERS: 2US FAERS
611Intracranial massFAERS: 2US FAERS
612Investigation abnormalFAERS: 2US FAERS
613Irregular breathingFAERS: 2US FAERS
614Joint Range of Motion DecreasedFAERS: 2US FAERS
615Lichen PlanusFAERS: 2US FAERS
616Limb massFAERS: 2US FAERS
617Limb operationFAERS: 2US FAERS
618Lip erythemaFAERS: 2US FAERS
619Lipase increasedFAERS: 2US FAERS
620Loose toothFAERS: 2US FAERS
621Low density lipoprotein increasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
622Lung neoplasm surgeryFAERS: 2US FAERS
623Lymph node abscessFAERS: 2US FAERS
624Meningeal disorderFAERS: 2US FAERS
625Metabolic acidosisFAERS: 2US FAERS
626MetamorphopsiaFAERS: 2US FAERS
627Metastases to adrenalsFAERS: 2US FAERS
628Metastatic painFAERS: 2US FAERS
629Mineral supplementationFAERS: 2US FAERS
630MonoparesisFAERS: 2US FAERS
631Muscle hypertrophyFAERS: 2US FAERS
632Myasthenia GravisFAERS: 2US FAERS
633NecrosisFAERS: 2US FAERS
634Negative thoughtsFAERS: 2US FAERS
635Ocular discomfortFAERS: 2US FAERS
636Oral infectionFAERS: 2US FAERS
637Orchitis noninfectiveFAERS: 2US FAERS
638OsteopeniaFAERS: 2US FAERS
639Pain managementFAERS: 2US FAERS
640ParacentesisFAERS: 2US FAERS
641ParaplegiaFAERS: 2US FAERS
642Pelvic discomfortFAERS: 2US FAERS
643Penile swellingFAERS: 2US FAERS
644PericarditisFAERS: 2US FAERS
645Perineal painFAERS: 2US FAERS
646Periorbital contusionFAERS: 2US FAERS
647Peripheral arterial occlusive diseaseFAERS: 2US FAERS
648Peripheral artery bypassFAERS: 2US FAERS
649Peripheral venous diseaseFAERS: 2US FAERS
650PetechiaeFAERS: 2US FAERS
651Phantom painFAERS: 2US FAERS
652PharyngitisFAERS: 2SIDER
US FAERS
653Poor quality product administeredFAERS: 2US FAERS
654Post procedural infectionFAERS: 2US FAERS
655Prescribed overdoseFAERS: 2US FAERS
656Product adhesion issueFAERS: 2US FAERS
657Product availability issueFAERS: 2US FAERS
658Product container issueFAERS: 2US FAERS
659Product container seal issueFAERS: 2US FAERS
660Product contaminationFAERS: 2US FAERS
661Product counterfeitFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
662Product difficult to swallowFAERS: 2US FAERS
663Product lot number issueFAERS: 2US FAERS
664ProteinuriaFAERS: 2US FAERS
665Pulmonary painFAERS: 2US FAERS
666PyelonephritisFAERS: 2US FAERS
667Radiation proctitisFAERS: 2US FAERS
668Renal massFAERS: 2US FAERS
669Respiratory tract congestionFAERS: 2US FAERS
670Selective eating disorderFAERS: 2US FAERS
671Sexual DysfunctionFAERS: 2US FAERS
672Silent myocardial infarctionFAERS: 2US FAERS
673Sinus headacheFAERS: 2US FAERS
674Skin ErosionFAERS: 2US FAERS
675Skin discomfortFAERS: 2US FAERS
676Skin reactionFAERS: 2US FAERS
677Small cell lung cancer metastaticFAERS: 2US FAERS
678Spinal column injuryFAERS: 2US FAERS
679Spinal fusion surgeryFAERS: 2US FAERS
680StaringFAERS: 2US FAERS
681Status EpilepticusFAERS: 2US FAERS
682Stem cell transplantFAERS: 2US FAERS
683StrabismusFAERS: 2US FAERS
684Tension HeadacheFAERS: 2US FAERS
685Therapeutic procedureFAERS: 2US FAERS
686Therapeutic response changedFAERS: 2US FAERS
687Therapy changeFAERS: 2US FAERS
688Thermal burnFAERS: 2US FAERS
689Thrombotic strokeFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
690Tongue erythemaFAERS: 2US FAERS
691TrismusFAERS: 2US FAERS
692Urethral StenosisFAERS: 2US FAERS
693UrethritisFAERS: 2US FAERS
694Urinary hesitationFAERS: 2US FAERS
695Vasculitic rashFAERS: 2US FAERS
696Venous ThrombosisFAERS: 2US FAERS
697Ventricular FibrillationFAERS: 2US FAERS
698Viral upper respiratory tract infectionFAERS: 2US FAERS
699cancer surgeryFAERS: 2US FAERS
700Accidental exposure to product by childFAERS: 1US FAERS
701Activated partial thromboplastin time abnormalFAERS: 1US FAERS
702Acute left ventricular failureFAERS: 1US FAERS
703Adrenal massFAERS: 1US FAERS
704Alcohol interactionFAERS: 1US FAERS
705Altered visual depth perceptionFAERS: 1US FAERS
706Ammonia abnormalFAERS: 1US FAERS
707AmyloidosisFAERS: 1US FAERS
708Amyotrophic Lateral SclerosisFAERS: 1US FAERS
709Anal abscessFAERS: 1US FAERS
710Anal inflammationFAERS: 1US FAERS
711Androgens decreasedFAERS: 1US FAERS
712Anorectal swellingFAERS: 1US FAERS
713Anti-androgen withdrawal syndromeFAERS: 1US FAERS
714Anticoagulant therapyFAERS: 1US FAERS
715Aortic RuptureFAERS: 1US FAERS
716Aortic Valve StenosisFAERS: 1US FAERS
717Aortic occlusionFAERS: 1US FAERS
718Arterial insufficiencyFAERS: 1US FAERS
719Aspartate aminotransferase abnormalFAERS: 1US FAERS
720AtelectasisFAERS: 1US FAERS
721Atypical fractureFAERS: 1US FAERS
722Bacterial sepsisFAERS: 1US FAERS
723Benign neoplasm of bladderFAERS: 1US FAERS
724Bile output decreasedFAERS: 1US FAERS
725Bipolar DisorderFAERS: 1US FAERS
726Bladder calculus removalFAERS: 1US FAERS
727Bladder dysfunctionFAERS: 1US FAERS
728Bladder sphincter atonyFAERS: 1US FAERS
729Bladder tamponadeFAERS: 1US FAERS
730Blister ruptureFAERS: 1US FAERS
731Blood bilirubin abnormalFAERS: 1US FAERS
732Blood chromogranin A increasedFAERS: 1US FAERS
733Blood cortisol decreasedFAERS: 1US FAERS
734Blood creatine increasedFAERS: 1US FAERS
735Blood creatinine decreasedFAERS: 1US FAERS
736Blood lactate dehydrogenase increasedFAERS: 1US FAERS
737Blood pressure inadequately controlledFAERS: 1US FAERS
738Blood sodium abnormalFAERS: 1US FAERS
739Blood sodium increasedFAERS: 1US FAERS
740Blood thyroid stimulating hormone abnormalFAERS: 1US FAERS
741Blood urea abnormalFAERS: 1US FAERS
742Blood viscosity abnormalFAERS: 1US FAERS
743Body temperature fluctuationFAERS: 1US FAERS
744Bone erosionFAERS: 1US FAERS
745Bone fissureFAERS: 1US FAERS
746BradykinesiaFAERS: 1US FAERS
747Brain AbscessFAERS: 1US FAERS
748Breathing-related sleep disorderFAERS: 1US FAERS
749BruxismFAERS: 1US FAERS
750Buccal mucosal rougheningFAERS: 1US FAERS
751Butterfly rashFAERS: 1US FAERS
752Capsule physical issueFAERS: 1US FAERS
753Carbon dioxide increasedFAERS: 1US FAERS
754Carcinoembryonic antigen increasedFAERS: 1US FAERS
755Cardiac DeathFAERS: 1US FAERS
756Cardiac infectionFAERS: 1US FAERS
757Cardiac neoplasm unspecifiedFAERS: 1US FAERS
758Cardioactive drug level increasedFAERS: 1US FAERS
759Cardiovascular insufficiencyFAERS: 1US FAERS
760Catheter managementFAERS: 1US FAERS
761Catheter site erythemaFAERS: 1US FAERS
762Cauda Equina SyndromeFAERS: 1SIDER
US FAERS
763Central nervous system massFAERS: 1US FAERS
764Cerebral ArteriosclerosisFAERS: 1US FAERS
765Cerebral ThrombosisFAERS: 1US FAERS
766Cerebral calcificationFAERS: 1US FAERS
767Cerebrospinal fluid circulation disorderFAERS: 1US FAERS
768CheilitisFAERS: 1US FAERS
769Cheyne-Stokes RespirationFAERS: 1US FAERS
770ChloasmaFAERS: 1US FAERS
771CholangiocarcinomaFAERS: 1US FAERS
772ChromatopsiaFAERS: 1US FAERS
773Chronic gastritisFAERS: 1US FAERS
774Clostridial sepsisFAERS: 1US FAERS
775Complication of device insertionFAERS: 1US FAERS
776ConjunctivitisFAERS: 1US FAERS
777Contracted bladderFAERS: 1US FAERS
778Corneal lesionFAERS: 1US FAERS
779Coronary angioplastyFAERS: 1US FAERS
780Coronary artery stent removalFAERS: 1US FAERS
781Creatinine renal clearance decreasedFAERS: 1US FAERS
782Croup infectiousFAERS: 1US FAERS
783Device leakageFAERS: 1US FAERS
784Diabetic FootFAERS: 1US FAERS
785Diaphragmatic HerniaFAERS: 1US FAERS
786DrowningFAERS: 1US FAERS
787Drug level decreasedFAERS: 1US FAERS
788Dry age-related macular degenerationFAERS: 1US FAERS
789DuodenitisFAERS: 1US FAERS
790DysbacteriosisFAERS: 1US FAERS
791DyscalculiaFAERS: 1US FAERS
792DysenteryFAERS: 1US FAERS
793DyslexiaFAERS: 1US FAERS
794DysphemiaFAERS: 1US FAERS
795DysplasiaFAERS: 1US FAERS
796EcchymosisFAERS: 1US FAERS
797Echocardiogram abnormalFAERS: 1US FAERS
798Elbow operationFAERS: 1US FAERS
799Electrocardiogram abnormalFAERS: 1US FAERS
800Electrocardiogram changeFAERS: 1US FAERS
801Electrolyte depletionFAERS: 1US FAERS
802Embolic strokeFAERS: 1US FAERS
803EmpyemaFAERS: 1US FAERS
804EncephalitisFAERS: 1US FAERS
805EndocarditisFAERS: 1US FAERS
806EndophthalmitisFAERS: 1US FAERS
807ErysipelasFAERS: 1US FAERS
808Erythema MultiformeFAERS: 1US FAERS
809Euphoric moodFAERS: 1US FAERS
810EuthanasiaFAERS: 1US FAERS
811ExcoriationFAERS: 1US FAERS
812Exfoliative rashFAERS: 1US FAERS
813Exostosis of jawFAERS: 1US FAERS
814Exposed bone in jawFAERS: 1US FAERS
815Exposure via body fluidFAERS: 1US FAERS
816Exposure via ingestionFAERS: 1US FAERS
817Exposure via partnerFAERS: 1US FAERS
818Expulsion of medicationFAERS: 1US FAERS
819Extremity contractureFAERS: 1US FAERS
820Extremity necrosisFAERS: 1US FAERS
821Eye inflammationFAERS: 1US FAERS
822Eyelids pruritusFAERS: 1US FAERS
823Flat affectFAERS: 1US FAERS
824Focal dyscognitive seizuresFAERS: 1US FAERS
825Food AllergyFAERS: 1US FAERS
826Foreign body sensation in eyesFAERS: 1US FAERS
827Gallbladder painFAERS: 1US FAERS
828Gastric LavageFAERS: 1US FAERS
829Gastric infectionFAERS: 1US FAERS
830Gastrointestinal PainFAERS: 1US FAERS
831Gastrointestinal carcinomaFAERS: 1US FAERS
832Gastrointestinal inflammationFAERS: 1US FAERS
833Gastrointestinal perforationFAERS: 1US FAERS
834Gastrointestinal stromal cancerFAERS: 1US FAERS
835Gastrostomy tube site complicationFAERS: 1US FAERS
836Genital discomfortFAERS: 1US FAERS
837Glioblastoma MultiformeFAERS: 1US FAERS
838GlioblastomaFAERS: 1US FAERS
839GlomerulonephritisFAERS: 1US FAERS
840Groin infectionFAERS: 1US FAERS
841Guillain-Barre SyndromeFAERS: 1US FAERS
842HaematinuriaFAERS: 1US FAERS
843HaematotoxicityFAERS: 1US FAERS
844Heat StrokeFAERS: 1US FAERS
845HemiplegiaFAERS: 1US FAERS
846Hepatic EncephalopathyFAERS: 1US FAERS
847Hilar lymphadenopathyFAERS: 1US FAERS
848Hormone level abnormalFAERS: 1US FAERS
849HydrocephalusFAERS: 1US FAERS
850HyperkinesiaFAERS: 1US FAERS
851HyperventilationFAERS: 1US FAERS
852HyporeflexiaFAERS: 1US FAERS
853Hyporesponsive to stimuliFAERS: 1US FAERS
854Hypotonic urinary bladderFAERS: 1US FAERS
855ImmunosuppressionFAERS: 1US FAERS
856Impaired gastric emptyingFAERS: 1US FAERS
857Impaired self-careFAERS: 1US FAERS
858Incorrect drug administration durationFAERS: 1US FAERS
859Increased bronchial secretionFAERS: 1US FAERS
860Infected cystFAERS: 1US FAERS
861Infectious pleural effusionFAERS: 1US FAERS
862Intercepted drug administration errorFAERS: 1US FAERS
863Intercepted drug prescribing errorFAERS: 1US FAERS
864Intercepted medication errorFAERS: 1US FAERS
865Intervertebral disc compressionFAERS: 1US FAERS
866Intra-abdominal fluid collectionFAERS: 1US FAERS
867Intraocular pressure testFAERS: 1US FAERS
868IritisFAERS: 1US FAERS
869Iron deficiencyFAERS: 1US FAERS
870Joint InstabilityFAERS: 1US FAERS
871Joint laxityFAERS: 1US FAERS
872LabyrinthitisFAERS: 1US FAERS
873Large intestine perforationFAERS: 1US FAERS
874Late onset hypogonadism syndromeFAERS: 1US FAERS
875LeukoencephalopathyFAERS: 1US FAERS
876Life expectancy shortenedFAERS: 1US FAERS
877Ligament injuryFAERS: 1US FAERS
878Ligament ruptureFAERS: 1US FAERS
879Limbic EncephalitisFAERS: 1US FAERS
880Lip and/or oral cavity cancerFAERS: 1US FAERS
881Lip neoplasm malignant stage unspecifiedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
882Living in residential institutionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
883Lupus-like syndromeFAERS: 1US FAERS
884Macular degenerationFAERS: 1US FAERS
885MaculeFAERS: 1US FAERS
886Male genital atrophyFAERS: 1US FAERS
887Male sexual dysfunctionFAERS: 1US FAERS
888Malignant neoplasm of spinal cordFAERS: 1US FAERS
889Malignant neoplasm of thoraxFAERS: 1US FAERS
890Malignant urinary tract obstructionFAERS: 1US FAERS
891MarasmusFAERS: 1US FAERS
892Mastication disorderFAERS: 1US FAERS
893Medical device complicationFAERS: 1US FAERS
894MegacolonFAERS: 1US FAERS
895MeningiomaFAERS: 1US FAERS
896Meniscus operationFAERS: 1US FAERS
897Mental FatigueFAERS: 1US FAERS
898Mental disorder due to a general medical conditionFAERS: 1US FAERS
899Metastases to abdominal cavityFAERS: 1US FAERS
900Metastases to pelvisFAERS: 1US FAERS
901Metastases to stomachFAERS: 1US FAERS
902Metastatic bronchial carcinomaFAERS: 1US FAERS
903MiliariaFAERS: 1US FAERS
904MoaningFAERS: 1US FAERS
905Morbid thoughtsFAERS: 1US FAERS
906Mouth BreathingFAERS: 1US FAERS
907Multifocal motor neuropathyFAERS: 1US FAERS
908MultimorbidityFAERS: 1US FAERS
909MutismFAERS: 1US FAERS
910MyopathyFAERS: 1US FAERS
911Nail InfectionFAERS: 1US FAERS
912Nail bed disorderFAERS: 1US FAERS
913Nail discomfortFAERS: 1US FAERS
914Near DrowningFAERS: 1US FAERS
915NephrectomyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
916NeuritisFAERS: 1US FAERS
917Neuroleptic Malignant SyndromeFAERS: 1US FAERS
918Neurological decompensationFAERS: 1US FAERS
919NeurosyphilisFAERS: 1US FAERS
920Neutropenic sepsisFAERS: 1US FAERS
921ObesityFAERS: 1US FAERS
922Obsessive-Compulsive DisorderFAERS: 1US FAERS
923Obstructive nephropathyFAERS: 1US FAERS
924Ocular HypertensionFAERS: 1US FAERS
925OliguriaFAERS: 1US FAERS
926OnycholysisFAERS: 1US FAERS
927OnychomycosisFAERS: 1US FAERS
928Optic NeuritisFAERS: 1US FAERS
929Oral mucosal eruptionFAERS: 1US FAERS
930Oral pruritusFAERS: 1US FAERS
931Organic brain syndromeFAERS: 1US FAERS
932Orthostatic hypertensionFAERS: 1US FAERS
933Osteitis DeformansFAERS: 1US FAERS
934OsteotomyFAERS: 1US FAERS
935Oxygen saturation abnormalFAERS: 1US FAERS
936Oxygen supplementationFAERS: 1US FAERS
937Pacemaker generated arrhythmiaFAERS: 1US FAERS
938Palliative CareFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
939Pancreatic carcinoma recurrentFAERS: 1US FAERS
940Pancreatic enzymes increasedFAERS: 1US FAERS
941ParanoiaFAERS: 1US FAERS
942Paresis anal sphincterFAERS: 1US FAERS
943ParotitisFAERS: 1US FAERS
944Penile burning sensationFAERS: 1US FAERS
945Peripheral artery thrombosisFAERS: 1US FAERS
946Peripheral arthritisFAERS: 1US FAERS
947PeritonitisFAERS: 1US FAERS
948PhlebitisFAERS: 1US FAERS
949Physical product label issueFAERS: 1US FAERS
950PiloerectionFAERS: 1US FAERS
951PlasmacytomaFAERS: 1US FAERS
952PoisoningFAERS: 1US FAERS
953PolyarthritisFAERS: 1US FAERS
954PolydipsiaFAERS: 1US FAERS
955Polymyalgia RheumaticaFAERS: 1US FAERS
956PolyuriaFAERS: 1US FAERS
957Portal Vein ThrombosisFAERS: 1US FAERS
958Post procedural complicationFAERS: 1US FAERS
959Potentiating drug interactionFAERS: 1US FAERS
960Procedural complicationFAERS: 1US FAERS
961ProctitisFAERS: 1US FAERS
962Product dispensing errorFAERS: 1US FAERS
963Product distribution issueFAERS: 1US FAERS
964Product label confusionFAERS: 1US FAERS
965Product prescribing errorFAERS: 1US FAERS
966Product solubility abnormalFAERS: 1US FAERS
967Product tamperingFAERS: 1US FAERS
968Prostatic ObstructionFAERS: 1US FAERS
969Protein total decreasedFAERS: 1US FAERS
970Prothrombin time abnormalFAERS: 1US FAERS
971PurgingFAERS: 1US FAERS
972PurpuraFAERS: 1US FAERS
973Pustular psoriasisFAERS: 1US FAERS
974Pyoderma GangrenosumFAERS: 1US FAERS
975QuadriplegiaFAERS: 1US FAERS
976RalesFAERS: 1US FAERS
977Rectal spasmFAERS: 1US FAERS
978Renal artery stent placementFAERS: 1US FAERS
979Rheumatic disorderFAERS: 1US FAERS
980RhinalgiaFAERS: 1US FAERS
981Rubber sensitivityFAERS: 1US FAERS
982Salt cravingFAERS: 1US FAERS
983SarcoidosisFAERS: 1US FAERS
984ScabFAERS: 1US FAERS
985SchizophreniaFAERS: 1US FAERS
986SclerodermaFAERS: 1US FAERS
987ScreamingFAERS: 1US FAERS
988Scrotal erythemaFAERS: 1US FAERS
989Sexual inhibitionFAERS: 1US FAERS
990ShockFAERS: 1US FAERS
991Skin hypertrophyFAERS: 1US FAERS
992Skin neoplasm excisionFAERS: 1US FAERS
993Skin toxicityFAERS: 1US FAERS
994Spinal cord herniationFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
995SplenomegalyFAERS: 1US FAERS
996Squamous cell carcinoma of skinFAERS: 1US FAERS
997Squamous cell carcinomaFAERS: 1US FAERS
998Stoma complicationFAERS: 1US FAERS
999Stoma site extravasationFAERS: 1US FAERS
1000SubileusFAERS: 1US FAERS
1001TensionFAERS: 1US FAERS
1002Testicular hypertrophyFAERS: 1US FAERS
1003Thalamic infarctionFAERS: 1US FAERS
1004Therapeutic product ineffectiveFAERS: 1US FAERS
1005Thoracic vertebral fractureFAERS: 1US FAERS
1006ThrombocytosisFAERS: 1US FAERS
1007ThrombophlebitisFAERS: 1US FAERS
1008Thyroid cancer metastaticFAERS: 1US FAERS
1009Time perception alteredFAERS: 1US FAERS
1010Tongue discomfortFAERS: 1US FAERS
1011TonsillectomyFAERS: 1US FAERS
1012Tooth AvulsionFAERS: 1US FAERS
1013Tooth repairFAERS: 1US FAERS
1014Toxic Shock SyndromeFAERS: 1US FAERS
1015Trigeminal NeuralgiaFAERS: 1US FAERS
1016Troponin T increasedFAERS: 1US FAERS
1017TuberculosisFAERS: 1US FAERS
1018UnderweightFAERS: 1US FAERS
1019Upper airway obstructionFAERS: 1US FAERS
1020Upper respiratory tract congestionFAERS: 1US FAERS
1021UrethrotomyFAERS: 1US FAERS
1022Urge IncontinenceFAERS: 1US FAERS
1023Urinary Tract PainFAERS: 1US FAERS
1024Urinary tract infection enterococcalFAERS: 1US FAERS
1025Vascular ruptureFAERS: 1US FAERS
1026Venous thrombosis limbFAERS: 1US FAERS
1027VerbigerationFAERS: 1US FAERS
1028Very low density lipoprotein increasedFAERS: 1US FAERS
1029Vessel perforationFAERS: 1US FAERS
1030Violence-related symptomFAERS: 1US FAERS
1031Vital functions abnormalFAERS: 1US FAERS
1032Vitamin D abnormalFAERS: 1US FAERS
1033Vocal Cord DysfunctionFAERS: 1US FAERS
1034Vocal Cord ParalysisFAERS: 1US FAERS
1035Waist circumference increasedFAERS: 1US FAERS
1036Wound decompositionFAERS: 1US FAERS
1037Wrong drug administeredFAERS: 1US FAERS
1038Wrong scheduleFAERS: 1US FAERS
1039XerodermaFAERS: 1US FAERS
1040YawningFAERS: 1US FAERS
1041colonoscopyFAERS: 1US FAERS
1042intensive careFAERS: 1US FAERS
1043prostatitisFAERS: 1US FAERS
1044Asthenic conditionsSIDER
1045Blood and lymphatic system disordersSIDER
1046InfestationSIDER
1047Mental impairment disordersSIDER
1048Product preparation issueCanada Vigilance: 1Canada Vigilance
1049Prostatic Neoplasms, Castration-Resistant

View details

CTD
1050Prostatic Neoplasms

View details

CTD
1051Triple Negative Breast Neoplasms27255535CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.